There are numerous practice guidelines available for bipolar disorder which cover both bipolar I and bipolar II. While no practice guidelines are a substitute for your clinical judgement and decision making, they can offer useful information and serve as a good reference. Many guidelines discuss use of medications like lithium and other mood stabilizers as well as antipsychotic medications during different phases of the illness including acute mania and bipolar depression. They also offer input on psychosocial interventions, lifestyle interventions, and managing co-morbid conditions. Most guidelines take up to a year to draft, and many are not updated for many years after release, so are not able to reflect the most current evidence. SMI Adviser has assembled a collection of current guidelines you can access. We do not endorse any but offer a variety each with a slightly different focus. They include ones from a commercial insurer, the American Psychiatric Association (APA), the British Association for Pharmacology (BAP), the Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD), and the European National Institute for Health and Care Excellence (NICE).
Guideline Watch: Practice Guideline for Patients with Bipolar Disorder, 2nd Edition (APA, published 2005)
Evidence-based guidelines for treating bipolar disorder: revised third edition recommendations from the British Association for Pharmacology (Journal of Psychopharmacology, published 2016)
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder (Bipolar Disorders, published 2018)